DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • United States
  • /
  • Healthcare
Author Program NEWCreate Narrative
SOLV logo

Solventum Corporation Stock Price

NYSE:SOLV Community·US$14.9b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 54 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

SOLV Share Price Performance

US$87.45
14.24 (19.45%)
​
US$93.15
Fair Value
US$87.45
14.24 (19.45%)
6.1% undervalued intrinsic discount
US$93.15
Fair Value
Price US$87.45
AnalystConsensusTarget US$93.15
AnalystLowTarget US$70.00
AnalystHighTarget US$113.00
Fri, 7 Aug 26
Fair ValueUS$93.15
Share Pricen/a

SOLV Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value US$93.15 6.1% undervalued intrinsic discount

SOLV: Portfolio Reshaping And Cost Controls Will Improve Outlook For 2025

0users have liked this narrative
0users have commented on this narrative
31users have followed this narrative
AN
AnalystLowTarget
AnalystLowTarget's
Fair Value
·
Fair Value US$70 24.9% overvalued intrinsic discount

Restructuring And Tariff Pressures Will Drive Margin Compression And Earnings Declines

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
AnalystHighTarget
AnalystHighTarget's
Fair Value
·
Fair Value US$113 22.6% undervalued intrinsic discount

Advanced Wound Care And Health Information Systems Will Transform Long Term Earnings Power

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
SOLV logo
Solventum
6.1% undervalued intrinsic discount

SOLV: Portfolio Reshaping And Cost Controls Will Improve Outlook For 2025

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 7 Aug
Read Narrative
SOLV logo
Solventum
24.9% overvalued intrinsic discount

Restructuring And Tariff Pressures Will Drive Margin Compression And Earnings Declines

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Updated 4 Sep
Read Narrative
SOLV logo
Solventum
22.6% undervalued intrinsic discount

Advanced Wound Care And Health Information Systems Will Transform Long Term Earnings Power

View narrative
AN
AnalystHighTarget
AnalystHighTarget
Updated 21 Aug
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystLowTarget
SOLV logo

SOLV: HIS Separation And Execution Risks Will Likely Cap Future Upside

Fair Value: US$70 24.9% overvalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystHighTarget
SOLV logo

SOLV: HIS Separation And ERP Cutover Execution Will Drive Early Repricing

Fair Value: US$113 22.6% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystConsensusTarget
SOLV logo

SOLV: HIS Separation Will Drive Future P/E Rerating Potential

Fair Value: US$93.15 6.1% undervalued intrinsic discount
31 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Undervalued with acceptable track record.

3 Risks
3 Rewards
View Full Analysis

Solventum Corporation Key Details

US$8.3b

Revenue

US$3.8b

Cost of Revenue

US$4.6b

Gross Profit

US$3.1b

Other Expenses

US$1.4b

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
8.42
54.78%
17.26%
106.0%
View Full Analysis

About SOLV

Founded
2023
Employees
20584
CEO
Bryan Hanson
WebsiteView website
www.solventum.com

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.

Recent SOLV News & Updates

User avatar
Narrative Update • Sep 04

SOLV: HIS Separation And Execution Risks Will Likely Cap Future Upside

The analyst fair value estimate for Solventum is now $70.00. This reflects higher Street price targets that focus on Q2 earnings, which were ahead of expectations, and the planned separation of the HIS segment, while still accounting for ongoing cost, dilution, and execution risks.
User avatar
Narrative Update • Aug 21

SOLV: HIS Separation And ERP Cutover Execution Will Drive Early Repricing

Solventum's analyst fair value estimate has risen from $100 to $113, reflecting updated expectations for slightly higher revenue growth and profit margins, along with a modestly lower discount rate. Recent Street research highlights the planned HIS separation and solid Q2 execution as key supports for the higher price targets.

Recent updates

No updates

Solventum Corporation Competitors

MDT logo

Medtronic

Symbol: NYSE:MDT
Market cap: US$116.4b
SYK logo

Stryker

Symbol: NYSE:SYK
Market cap: US$105.7b
MCK logo

McKesson

Symbol: NYSE:MCK
Market cap: US$102.8b
HCA logo

HCA Healthcare

Symbol: NYSE:HCA
Market cap: US$92.4b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide